SI
Basic information
Region (hg38): 3:164978898-165078496
Links
Phenotypes
GenCC
Source:
- congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
- congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
- congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
- congenital sucrase-isomaltase deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Sucrase-isomaltase deficiency, congenital | AR | Gastrointestinal | Sucrose and other carbohydrate ingestion results in osmotic diarrhea, and dietary/medical therapy (eg, sucrose-reduced diet, treatment with sacrosidase) can be effective | Gastrointestinal | 5848222; 6082247; 925457; 3553946; 3807985; 3403721; 1717481; 8648532; 8609217; 8648527; 9932843; 10445568; 10903344; 11340066; 12014995; 14724820; 16329100; 18043509; 19680155; 23103650; 23103652; 23103658 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (45 variants)
- Sucrase-isomaltase deficiency (5 variants)
- SI-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 195 | 210 | ||||
missense | 469 | 20 | 497 | |||
nonsense | 21 | 27 | ||||
start loss | 1 | |||||
frameshift | 27 | 33 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 29 | 29 | ||||
splice region | 34 | 54 | 7 | 95 | ||
non coding | 16 | 208 | 16 | 240 | ||
Total | 48 | 41 | 500 | 424 | 30 |
Highest pathogenic variant AF is 0.0000395
Variants in SI
This is a list of pathogenic ClinVar variants found in the SI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-164978936-C-T | Sucrase-isomaltase deficiency | Benign (Jan 13, 2018) | ||
3-164979047-TA-T | Sucrase-isomaltase deficiency | Likely benign (Jun 14, 2016) | ||
3-164979133-A-G | Sucrase-isomaltase deficiency | Uncertain significance (Jan 13, 2018) | ||
3-164979145-T-G | Sucrase-isomaltase deficiency | Uncertain significance (Jan 12, 2018) | ||
3-164979164-C-A | Sucrase-isomaltase deficiency | Benign (Apr 27, 2017) | ||
3-164979211-T-C | Sucrase-isomaltase deficiency | Uncertain significance (Jan 13, 2018) | ||
3-164979241-G-A | Sucrase-isomaltase deficiency | Uncertain significance (Jan 13, 2018) | ||
3-164979294-A-G | Sucrase-isomaltase deficiency | Benign (Jan 12, 2018) | ||
3-164979365-T-C | Likely benign (Nov 04, 2022) | |||
3-164979380-T-G | Likely benign (May 31, 2022) | |||
3-164979382-T-C | Uncertain significance (Jun 13, 2022) | |||
3-164979385-G-A | Uncertain significance (Aug 16, 2022) | |||
3-164979386-T-A | Inborn genetic diseases | Uncertain significance (May 09, 2023) | ||
3-164979400-C-T | Uncertain significance (Mar 12, 2022) | |||
3-164979400-CAT-C | Uncertain significance (Jul 29, 2022) | |||
3-164979418-C-T | Uncertain significance (Aug 25, 2021) | |||
3-164979423-C-T | SI-related disorder | Likely benign (Dec 25, 2023) | ||
3-164979444-A-G | Likely benign (Apr 06, 2023) | |||
3-164982223-T-C | Likely benign (Aug 17, 2023) | |||
3-164982233-C-T | Likely benign (Dec 28, 2023) | |||
3-164982234-A-G | Likely benign (Nov 28, 2023) | |||
3-164982253-G-C | Sucrase-isomaltase deficiency | Benign (Jan 29, 2024) | ||
3-164982255-G-A | Sucrase-isomaltase deficiency | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
3-164982265-A-C | Sucrase-isomaltase deficiency • Inborn genetic diseases | Uncertain significance (Dec 14, 2023) | ||
3-164982273-C-A | Likely benign (Jul 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SI | protein_coding | protein_coding | ENST00000264382 | 47 | 99598 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.94e-60 | 3.03e-7 | 125417 | 0 | 330 | 125747 | 0.00131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.08 | 1067 | 972 | 1.10 | 0.0000497 | 12024 |
Missense in Polyphen | 316 | 328.22 | 0.96277 | 3998 | ||
Synonymous | -2.29 | 373 | 321 | 1.16 | 0.0000166 | 3308 |
Loss of Function | 1.18 | 99 | 112 | 0.880 | 0.00000544 | 1344 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00229 | 0.00220 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000493 | 0.000489 |
Finnish | 0.000602 | 0.000601 |
European (Non-Finnish) | 0.00169 | 0.00166 |
Middle Eastern | 0.000493 | 0.000489 |
South Asian | 0.00185 | 0.00180 |
Other | 0.000818 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in the final stage of carbohydrate digestion. Isomaltase activity is specific for both alpha-1,4- and alpha-1,6-oligosaccharides. {ECO:0000269|PubMed:20356844}.;
- Disease
- DISEASE: Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]: Autosomal recessive intestinal disorder that is clinically characterized by fermentative diarrhea, abdominal pain, and cramps upon ingestion of sugar. The symptoms are the consequence of absent or drastically reduced enzymatic activities of sucrase and isomaltase. The prevalence of CSID is 0.02 % in individuals of European descent and appears to be much higher in Greenland, Alaskan, and Canadian native people. CSID arises due to post-translational perturbations in the intracellular transport, polarized sorting, aberrant processing, and defective function of SI. {ECO:0000269|PubMed:10903344, ECO:0000269|PubMed:11340066, ECO:0000269|PubMed:14724820, ECO:0000269|PubMed:16329100, ECO:0000269|PubMed:8609217}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Starch and sucrose metabolism - Homo sapiens (human);Carbohydrate digestion and absorption - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Starch and Sucrose Metabolism;Digestion of dietary carbohydrate;Digestion;Digestion and absorption;sucrose degradation
(Consensus)
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.0899
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.62
Haploinsufficiency Scores
- pHI
- 0.0721
- hipred
- N
- hipred_score
- 0.422
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.586
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sis
- Phenotype
Gene ontology
- Biological process
- carbohydrate metabolic process;polysaccharide digestion
- Cellular component
- Golgi apparatus;plasma membrane;brush border;integral component of membrane;apical plasma membrane;extracellular exosome
- Molecular function
- alpha-1,4-glucosidase activity;oligo-1,6-glucosidase activity;sucrose alpha-glucosidase activity;carbohydrate binding